Sectors

The cancer, autoimmune and rare disease drug developer completed a $65m round that also featured MRL Ventures Fund and Cleva Pharma.

Access Industries' Access Biotechnology unit has contributed to a series A round for the paediatric oncology drug developer.

Stanford’s proteomic analysis spinout has lifted its funding haul beyond $100m with a round set to drive new hires and technology development.

Oxford Nanopore has added $59.6m to its latest funding round to bring the round to $98.1m and its overall funding to nearly $692m.

Nanoform has filed for a dual listing in Sweden and Finland, marking the first time that a University of Helsinki spinout is seeking an initial public offering.

The Mandatum Life and Ilmarinen-backed nanoparticle technology developer has priced a $76.7m offering that will take place in Sweden and Finland.

Wayra-backed consumer loan provider Addi has boosted its total funding to nearly $32m as it prepares to move into Brazil and Mexico.

Biogen and GlaxoSmithKline-backed CalciMedica has received series C capital to advance a possible Covid-19 treatment through clinical testing.

Trip.com participated in a $14m series B-plus round for the hotel management software provider through subsidiary Shanghai Kehui Investment.

The auto insurance provider secured $18.3m in a round led by CommerzBank’s investment arm that lifted its overall funding to more than $26m.

Poste Italiane has taken part in a $27.2m round for the last-mile delivery service having already launched a strategic partnership in January.